UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prediction and constancy of cognitive-motivational structures in mothers and their adolescents

Child psychiatry and human development, 1995-03, Vol.25 (3), p.197-208

1995

Volltextzugriff (PDF)

Creativity and related processes in the young child: a review of the literature

The Journal of genetic psychology, 1968-03, Vol.112 (1st Half), p.77-108

Arasteh, J D

1968

Volltextzugriff (PDF)

Parenthood: Some Antecedents and Consequences: A Preliminary Survey of the Mental Health Literature

The Journal of genetic psychology, 1971-06, Vol.118 (2), p.179-202

Arasteh, Josephine D.

1971

Volltextzugriff (PDF)

Epithelial IL-22RA1-Mediated Fucosylation Promotes Intestinal Colonization Resistance to an Opportunistic Pathogen

Cell host & microbe, 2014-10, Vol.16 (4), p.504-516

2014

Volltextzugriff (PDF)

Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US

PloS one, 2018-03, Vol.13 (3), p.e0194799

2018

Volltextzugriff (PDF)

Coping With Health Threats: The Costs and Benefits of Managing Emotions

Psychological science, 2021-07, Vol.32 (7), p.1011-1023

2021

Volltextzugriff (PDF)

Prediction of the mechanical characteristics of multi-walled carbon nanotube/epoxy composites using a new form of the rule of mixtures

Carbon (New York), 2010-09, Vol.48 (11), p.3218-3228

2010

Volltextzugriff (PDF)

Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection

The New England journal of medicine, 2013-11, Vol.369 (19), p.1807-1818

2013

Volltextzugriff (PDF)

Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

The New England journal of medicine, 2008-07, Vol.359 (4), p.339-354

2008

Volltextzugriff (PDF)

The late‐presenting HIV‐infected patient 30 years after the introduction of HIV testing: spectrum of opportunistic diseases and missed opportunities for early diagnosis

HIV medicine, 2017-02, Vol.18 (2), p.125-132

2017

Volltextzugriff (PDF)

Geographic distribution of risk ("Hotspots") for HIV, HCV, and drug overdose among persons who use drugs in New York City: the importance of local history

Harm reduction journal, 2019-09, Vol.16 (1), p.53-12, Article 53

2019

Volltextzugriff (PDF)

Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection

The New England journal of medicine, 2008-07, Vol.359 (4), p.355-365

2008

Volltextzugriff (PDF)

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials

The Lancet infectious diseases, 2013-07, Vol.13 (7), p.587-596

2013

Volltextzugriff (PDF)

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study

The Lancet (British edition), 2008-08, Vol.372 (9639), p.646-655

2008

Volltextzugriff (PDF)

Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia

The New England journal of medicine, 2003-05, Vol.348 (22), p.2186-2195

2003

Volltextzugriff (PDF)

Ritonavir-Boosted Tipranavir Demonstrates Superior Efficacy to Ritonavir-Boosted Protease Inhibitors in Treatment-Experienced HIV-Infected Patients: 24-Week Results of the RESIST-2 Trial

Clinical infectious diseases, 2006-11, Vol.43 (10), p.1347-1356

2006

Volltextzugriff (PDF)

Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

HIV medicine, 2015-04, Vol.16 (S1), p.46-54

2015

Volltextzugriff (PDF)

An Individualized Multi-Modal Approach for Detection of Medication "Off" Episodes in Parkinson's Disease via Wearable Sensors

Journal of personalized medicine, 2023-01, Vol.13 (2), p.265

2023

Volltextzugriff (PDF)

Increased Methamphetamine Use among Persons Who Inject Drugs in Hai Phong, Vietnam, and the Association with Injection and Sexual Risk Behaviors

Journal of psychoactive drugs, 2018-10, Vol.50 (5), p.382-389

2018

Volltextzugriff (PDF)

HIV Incidence Among Injection Drug Users in New York City, 1990 to 2002: Use of Serologic Test Algorithm to Assess Expansion of HIV Prevention Services

American journal of public health (1971), 2005-08, Vol.95 (8), p.1439-1444

2005

Volltextzugriff (PDF)

Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001

AIDS (London), 2005-10, Vol.19 Suppl 3 (Suppl 3), p.S20-S25

2005

Volltextzugriff (PDF)

Combined HIV Prevention, the New York City Condom Distribution Program, and the Evolution of Safer Sex Behavior Among Persons Who Inject Drugs in New York City

AIDS and behavior, 2014-03, Vol.18 (3), p.443-451

2014

Volltextzugriff (PDF)

Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trials

Journal of acquired immune deficiency syndromes (1999), 2005-12, Vol.40 (4), p.404-412

2005

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(66)

Publikationsform

Artikel
(80)
Tagungsberichte
(1)

Sprache

Englisch
(77)
Deutsch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(65)
Life Sciences & Biomedicine
(58)
Humans
(55)
Female
(46)
Male
(45)
Adult
(44)
Human Immunodeficiency Virus
(39)
Infectious Diseases
(39)
Hiv
(35)
Hiv Infections - Drug Therapy
(33)
Middle Aged
(31)
Biological And Medical Sciences
(27)
Medical Sciences
(25)
Human Viral Diseases
(19)
Viral Diseases
(19)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(18)
Drug Therapy, Combination
(17)
Antiretroviral Drugs
(16)
Cd4 Lymphocyte Count
(16)
Immunology
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prediction and constancy of cognitive-motivational structures in mothers and their adolescents

Creativity and related processes in the young child: a review of the literature

Parenthood: Some Antecedents and Consequences: A Preliminary Survey of the Mental Health Literature

Epithelial IL-22RA1-Mediated Fucosylation Promotes Intestinal Colonization Resistance to an Opportunistic Pathogen

Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US

Coping With Health Threats: The Costs and Benefits of Managing Emotions

Prediction of the mechanical characteristics of multi-walled carbon nanotube/epoxy composites using a new form of the rule of mixtures

Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection

Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials

The late‐presenting HIV‐infected patient 30 years after the introduction of HIV testing: spectrum of opportunistic diseases and missed opportunities for early diagnosis

Geographic distribution of risk ("Hotspots") for HIV, HCV, and drug overdose among persons who use drugs in New York City: the importance of local history

Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study

Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia

Long-Term Efficacy and Safety of Raltegravir Combined with Optimized Background Therapy in Treatment-Experienced Patients with Drug-Resistant HIV Infection: Week 96 Results of the BENCHMRK 1 and 2 Phase III Trials

Ritonavir-Boosted Tipranavir Demonstrates Superior Efficacy to Ritonavir-Boosted Protease Inhibitors in Treatment-Experienced HIV-Infected Patients: 24-Week Results of the RESIST-2 Trial

Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

An Individualized Multi-Modal Approach for Detection of Medication "Off" Episodes in Parkinson's Disease via Wearable Sensors

Increased Methamphetamine Use among Persons Who Inject Drugs in Hai Phong, Vietnam, and the Association with Injection and Sexual Risk Behaviors

HIV Incidence Among Injection Drug Users in New York City, 1990 to 2002: Use of Serologic Test Algorithm to Assess Expansion of HIV Prevention Services

Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001

Combined HIV Prevention, the New York City Condom Distribution Program, and the Evolution of Safer Sex Behavior Among Persons Who Inject Drugs in New York City

Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trials

Suchergebnisse filtern